Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SYF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFG3L1P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SH2D1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928323 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF510 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00424 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANHX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RARB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGEA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF2IP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507389 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF512B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on